Abstract Hot flashes (HF) are a common adverse event of prolonged tamoxifen use in women with estrogen receptor-positive breast cancer. impacting psychiatric health and quality of life. While desvenlafaxine does not interact with tamoxifen. its efficacy and safety in breast cancer patients remain unstudied. https://www.lightemupsequences.com/great-deal-RVCA-Womens-Day-DreamTops-in-Periwinkle-mega-pick/
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial
Internet - 18 minutes ago pitmkyz8489ywWeb Directory Categories
Web Directory Search
New Site Listings